ArticleJournal of the National Cancer Center2024

The role of radiotherapy in patients with refractory Hodgkin's lymphoma after treatment with brentuximab vedotin and/or immune checkpoint inhibitors.

Ruizhi Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.